A214870 Stock Overview
NewGLAB Pharma CO.,LTD provides CCTV video security solutions in South Korea and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NewGLAB Pharma CO.,LTD Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,383.00 |
52 Week High | ₩15,050.00 |
52 Week Low | ₩1,356.00 |
Beta | 0.28 |
1 Month Change | 0% |
3 Month Change | -27.44% |
1 Year Change | -86.51% |
3 Year Change | -91.11% |
5 Year Change | -59.32% |
Change since IPO | -68.02% |
Recent News & Updates
Shareholder Returns
A214870 | KR Electronic | KR Market | |
---|---|---|---|
7D | 0% | -0.3% | -0.7% |
1Y | -86.5% | -22.5% | -5.5% |
Return vs Industry: A214870 underperformed the KR Electronic industry which returned -12.7% over the past year.
Return vs Market: A214870 underperformed the KR Market which returned 8% over the past year.
Price Volatility
A214870 volatility | |
---|---|
A214870 Average Weekly Movement | n/a |
Electronic Industry Average Movement | 6.9% |
Market Average Movement | 6.8% |
10% most volatile stocks in KR Market | 12.9% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A214870's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A214870's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 23 | Yoon-Hwa Ko | newglab.com |
NewGLAB Pharma CO.,LTD provides CCTV video security solutions in South Korea and internationally. The company offers network cameras, analog cameras, and ACCs under the HDPRO name, as well as technical support services. It also provides VR solutions; and distributes 5G smart phone accessories and daily supplies, including wireless earphones and vacuum cleaners, ninebots, and toothbrush sterilizers.
NewGLAB Pharma CO.,LTD Fundamentals Summary
A214870 fundamental statistics | |
---|---|
Market cap | ₩45.81b |
Earnings (TTM) | -₩73.18b |
Revenue (TTM) | ₩18.57b |
2.5x
P/S Ratio-0.6x
P/E RatioIs A214870 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A214870 income statement (TTM) | |
---|---|
Revenue | ₩18.57b |
Cost of Revenue | ₩15.78b |
Gross Profit | ₩2.79b |
Other Expenses | ₩75.98b |
Earnings | -₩73.18b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.21k |
Gross Margin | 15.04% |
Net Profit Margin | -394.10% |
Debt/Equity Ratio | -131.0% |
How did A214870 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/06/06 18:24 |
End of Day Share Price | 2023/03/09 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NewGLAB Pharma CO.,LTD is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jongsun Park | Eugene Investment & Securities Co Ltd. |